Company Profile

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE927.255.45 (+0.59 % )
PREV CLOSE (Rs.) 921.80
OPEN PRICE (Rs.) 921.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 141362
TODAY'S LOW / HIGH (Rs.)918.30 929.50
52 WK LOW / HIGH (Rs.)701.5 997.2
NSE928.15 7.1 (+0.77 % )
PREV CLOSE(Rs.) 921.05
OPEN PRICE (Rs.) 925.00
BID PRICE (QTY) 928.15 (176 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2014511
TODAY'S LOW / HIGH(Rs.) 918.50 929.55
52 WK LOW / HIGH (Rs.)703.2 997

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.54
TTM EPS (Rs.) 30.60
P/E Ratio 30.30
Book Value (Rs.) 246.60
Face Value (Rs.) 2
MCap (Rs. in Mn) 747959.22
Price/Earning (TTM) 24.84
Price/Sales (TTM) 5.38
Price/Book (MRQ) 3.76
PAT Margin (%) 16.72
ROCE (%) 18.19
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS More
03Aug08-03-2021$Cipla informs about newspaper advertisements Cipla informs about newspape

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it has enclosed the copies of newspaper advertisements published in ‘Business Standard (English) and Sakal (Marathi)’ on 2nd August, 2021 which includes the following information: Intimation of 85th AGM of the Company to be held on Wednesday, 25th August, 2021, at 3.00 pm IST through video conferencing (VC)/ other audio-visual means (OAVM) and completion of email dissemination on 1st August, 2021 of the Notice of AGM and Annual Report for financial year 2020-21 to the members whose email IDs are registered with the Company; and particulars regarding the facility of remote e-voting provided to Shareholders of the Company, to enable them to cast their votes on the resolutions proposed to be passed at the AGM. With regard to the enclosed notice published in Business Standard (English), the year mentioned under the head of ‘End of remote e-voting’ inadvertently got published as 2020 instead of 2021. The statement with the corrected date be read as ‘End of remote e-Voting - Tuesday, 24th August, 2021 (upto 5:00 pm IST)’.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
02Aug08-02-2021$Cipla informs about notice of AGM Cipla informs about notice o
Cipla has informed that in reference to the Notice of Annual General Meeting of Cipla 2020-21 filed with the stock exchanges on 31st July, 2021. The company informed that inadvertently it omitted to mention in the AGM notice the day of the meeting, Wednesday. Also, in the covering letter to the Stock exchange, the end date for remote e-voting was erroneously mentioned as 25th August, 2021 instead of 24th August, 2021. The updated AGM Notice is enclosed herewith and the corrected e-voting dates are mentioned herein below. 'The remote e-voting facility commences on Saturday, 21st August, 2021 from 9.00 am (IST) and ends on Tuesday, 24th August, 2021 at 5.00 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Ciplahas informed that in reference to the Notice of Annual Gen..
28Jul07-28-2021$Cipla informs about conference call Cipla informs about conferen
Cipla has informed that it enclosed the schedule of Earnings Conference Call to be held on 5th August 2021.

The above information is a part of company’s filings submitted to BSE.

Cipla has informed that it enclosed the schedule of Earnings Co..
26Jul07-26-2021$Cipla recalls 7,228 bottles of Solifenacin Succinate tablets Cipla recalls 7,228 bottles

Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market due to manufacturing issues. The company is recalling 10 mg, 30-count bottles in the US. The company has initiated the recall on June 10 this year and the USFDA has classified it as a Class II recall.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla is recalling 7,228 bottles of Solifenacin Succinate table..
17Jul07-17-2021$Cipla informs about allotment of equity shares under ESOP Cipla informs about allotmen

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that the Operations and Administrative Committee of the Company on 17th July, 2021 has allotted 45,704 equity shares of Rs 2 each pursuant to exercise of the stock options by the option grantees under Employee Stock Option Scheme 2013-A of the Company. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,32,84,914 comprising of 80,66,42,457 equity shares of face value Rs 2 each.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit4134.124682.8
Gross Profit 5531.8 33506.6
Operating Profit 6990.339518.4
Net Sales 32331.2139005.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
NGL Fine-Chem (BSE)
 3609.00 (5.00%)
M.Cap ( in Cr)
2229.65
Divi's Lab (BSE)
 5007.95 (1.62%)
M.Cap ( in Cr)
132945.34
Glaxosmithkline Phar (BSE)
 1682.75 (4.84%)
M.Cap ( in Cr)
28506.80
SMS Lifesciences (BSE)
 776.60 (7.57%)
M.Cap ( in Cr)
234.79
Procter&Gamble Healt (BSE)
 5492.75 (0.94%)
M.Cap ( in Cr)
9117.63
Shareholding Pattern More
PROMOTERS 36.72 %
NON-INSTITUTION 22.21 %
FI/BANKS/INSURANCE 2.55 %
MUTUAL FUNDS/UTI 13.36 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes